Mylanta liquid recalled for undisclosed alcohol
Johnson & Johnson-Merck Consumer announced a recall of twelve products from its liquid Mylanta product line and one liquid AlternaGEL product.
Hyperacidity/GERD/Ulcers
FDA Video: Avoiding Maalox Mix-ups
All liquid Maalox products are not the same. Maalox Total Relief, Maalox Advanced Regular Strength, and Maalox Advanced Maximum Strength may look similar but they are not interchangeable. In fact, using the wrong one could be harmful.
FDA Video: Mixups between Kapidex and Casodex
The Institute for Safe Medication Practices (ISMP) has reported medication errors due to name confusion between Kapidex (dexlansoprazole) and Casodex (bicalutamide). Kapidex is used to treat erosive esophagitis and gastroesophageal reflux disease. Casodex is used in combination therapy to treat metastatic prostate carcinoma, and is contraindicated in women. Patients who receive either drug because of a name mixup could experience unintended drug effects or adverse events.
NDA submitted for Xifaxan for treatment of non-constipation irritable bowel syndrome
Salix Pharmaceuticals announced that a New Drug Application (NDA) has been submitted to the FDA seeking approval of Xifaxan (rifaximin 550 mg tablets) for the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS) and IBS-related bloating.
Proton pump inhibitors (PPIs) class labeling change to include fracture risk
The FDA has notified healthcare professionals and patients of labeling changes for prescription and over-the-counter (OTC) proton pump inhibitors (PPIs) to include new safety information about a possible increased risk of fractures with the use of these medications.
